HeartSine Technologies, Inc. (HST) was founded in 1997 for the purpose of developing a family of products focused on an emerging growth segment of the medical device marketplace. We established our R&D activities in Northern Ireland and initiated a formal collaboration with the University of Ulster's Bioengineering Centre (NIBEC) and its partner, the Royal Victoria (RVH) a local teaching hospital, to augment and enhance our in-house development activities. The R&D team assembled in Ireland has a proven history in the development of unique technology and products for cardiology applications, specifically in the field of emergency cardiac care. Our engineering team has focused on developing leading edge, innovative technology components for use in the manufacture of a new generation of products, known as Automated External Defibrillators (AED), that will provide life saving therapy to victims of sudden cardiac arrest (SCA) or heart attack.